BLUJEPA

gepotidacin · GlaxoSmithKline LLC

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BLUJEPA, covering 2025-03-25 to 2025-12-11. Get the full timeline:

Most recent: FDA Approved: BLUJEPA — Supplemental Application (GlaxoSmithKline LLC)